1 citations,
January 2024 in “Curēus” Clinicians should use social and prescription data to track trends in performance-enhancing drug use.
1 citations,
December 2023 in “Curēus” Most children with a common hemochromatosis genotype had elevated iron levels but no severe symptoms.
1 citations,
November 2023 in “Curēus” Early diagnosis and treatment of nail and skin conditions can improve health and appearance.
1 citations,
June 2023 in “International journal of basic science in medicine” Adiantum capillus-veneris may help with respiratory issues, but more research is needed.
1 citations,
January 2023 in “Revista da Associação Médica Brasileira” Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.
1 citations,
November 2018 in “Journal of pathology and translational medicine” Fetal death was caused by umbilical cord stricture with hair growth in the Wharton jelly.
1 citations,
February 2018 in “Orthopedics and rheumatology” Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.
1 citations,
December 1999 in “Dermatologic Surgery” Propofol-ketamine and propofol-fentanyl are effective and safe for cosmetic surgery sedation.
December 2024 in “Cureus” This case report details a man in his 40s with a long-standing history of recalcitrant folliculitis decalvans (FD), who showed significant improvement in symptoms and hair regrowth after using tirzepatide for weight management. Previously ineffective treatments had failed to alleviate his condition, but tirzepatide, a GLP-1 receptor agonist, led to reduced pain, drainage, and flares, along with notable hair regrowth. These results suggest that tirzepatide may have beneficial anti-inflammatory and immunomodulatory effects for managing FD, indicating the need for further research into the therapeutic potential of GLP-1 agonists for FD and similar inflammatory skin conditions.
December 2024 in “Deleted Journal” New therapies show promise for wound healing, but more research is needed for safe, affordable options.
COVID-19 can cause significant hair loss.
Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.
Injectable PRF therapy may help with hair growth and skin rejuvenation, but more research is needed.
June 2024 in “Research Square (Research Square)” Copper deficiency is linked to post-COVID-19 hair loss in women.
May 2024 in “Journal of Education, Health and Sport” Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.
Stopping finasteride and closing PFO can help prevent strokes in young adults.
A 32-year-old man with early graying hair shows a unique pattern, suggesting more research is needed on why hair grays early.
April 2024 in “Proceedings” People with alopecia areata often have lower iron levels than healthy people.
Sunekos® effectively improves labia majora appearance and is well-tolerated.
Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.
Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.
Doctors should consider Netherton syndrome in patients with chronic skin and hair issues to avoid misdiagnosis.
A rapid screening method using trichoscopy and clinical data can improve diagnosis and treatment of tinea capitis.
Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.
Ziziphus jujuba and Eclipta alba leaf extracts improve blood sugar levels and cognitive function in diabetic rats.
February 2024 in “Curēus” Secukinumab can cause hair loss, which may improve after stopping the medication.
February 2024 in “Curēus” Regional nerve blocks are better than ring blocks for pain relief during PRP hair treatment.
January 2024 in “Burns and trauma” The skin microbiome helps heal wounds and can be targeted to improve healing.
December 2023 in “Curēus” Surgical removal of a scalp keratoacanthoma is effective and prevents recurrence, but hair may not regrow.
December 2023 in “Curēus” COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.